141 related articles for article (PubMed ID: 6325855)
1. Etoposide (VP 16-213; VePesid).
Med Lett Drugs Ther; 1984 May; 26(661):48-9. PubMed ID: 6325855
[No Abstract] [Full Text] [Related]
2. Does etoposide have curative potential?
Ignoffo RJ
Clin Pharm; 1983; 2(2):167. PubMed ID: 6309470
[No Abstract] [Full Text] [Related]
3. Etoposide (VP-16-213). Current status of an active anticancer drug.
O'Dwyer PJ; Leyland-Jones B; Alonso MT; Marsoni S; Wittes RE
N Engl J Med; 1985 Mar; 312(11):692-700. PubMed ID: 2983208
[No Abstract] [Full Text] [Related]
4. [Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].
Goldhirsch A; Joss R; Cavalli F; Sonntag RW; Ryssel HJ; Brunner KW
Dtsch Med Wochenschr; 1981 Aug; 106(35):1105-9. PubMed ID: 6266800
[No Abstract] [Full Text] [Related]
5. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
Sanz Ortíz J; Saiz García F
Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
[No Abstract] [Full Text] [Related]
6. VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy.
Tempero M; Kessinger A; Lemon HM
Cancer Clin Trials; 1981; 4(2):155-7. PubMed ID: 6265110
[No Abstract] [Full Text] [Related]
7. Phase II trial of etoposide in previously treated small cell carcinoma of the lung.
Antman K; Pomfret E; Karp G; Skarin A; Canellos G
Cancer Treat Rep; 1984 Nov; 68(11):1413-4. PubMed ID: 6094004
[No Abstract] [Full Text] [Related]
8. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
[No Abstract] [Full Text] [Related]
9. Etoposide in small cell lung cancer resistant to prior chemotherapy.
Asbury RF; Rubins J; Bennett JM
Cancer Treat Rep; 1983 Oct; 67(10):951-2. PubMed ID: 6313187
[No Abstract] [Full Text] [Related]
10. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD
Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694
[No Abstract] [Full Text] [Related]
11. Review of etoposide.
Phillips NC; Lauper RD
Clin Pharm; 1983; 2(2):112-9. PubMed ID: 6309469
[No Abstract] [Full Text] [Related]
12. Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
Issell BF; Einhorn LH; Comis RL; Lawson RD; Baker LH; Harvey HA; Lanzotti VA; Wampler GL; Daniels JR; Anderson PN
Cancer Treat Rep; 1985 Jan; 69(1):127-8. PubMed ID: 2981617
[No Abstract] [Full Text] [Related]
13. [Phase II study of VP-16 in patients with primary bronchogenic carcinoma, with special reference to small cell carcinoma--a multi-institutional cooperative study].
Kanda T; Oka M; Hara K; Koteda T; Ishizaki T; Ikebe A; Nakano M; Iwasaki H; Tsutsumi T; Okuno K
Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):12-8. PubMed ID: 3009666
[No Abstract] [Full Text] [Related]
14. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Radice PA; Bunn PA; Ihde DC
Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
[No Abstract] [Full Text] [Related]
15. [Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma].
Kurita Y; Yokoyama A; Kinameri K; Matsuura N; Sano K
Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):108-11. PubMed ID: 3009665
[No Abstract] [Full Text] [Related]
16. [Effects of oral etoposide in small cell carcinoma of the lung].
Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Kawakami Y; Shimizu T; Onodera S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1244-7. PubMed ID: 6329103
[TBL] [Abstract][Full Text] [Related]
17. VP-16-213 and cyclophosphamide in small cell lung cancer: a long-term followup report.
Britell JC; Eagan RT; Lee RE
Cancer Treat Rep; 1979; 63(11-12):2130-1. PubMed ID: 230899
[No Abstract] [Full Text] [Related]
18. High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lung.
Wolff SN; Johnson DH; Hande KR; Hainsworth JD; Greco FA
Cancer Treat Rep; 1983 Oct; 67(10):957-8. PubMed ID: 6313189
[No Abstract] [Full Text] [Related]
19. Treatment strategies in relation to drug action.
Muggia FM; McVie G
NCI Monogr; 1987; (4):129-33. PubMed ID: 2819724
[No Abstract] [Full Text] [Related]
20. Probable cure of small cell carcinoma of the lung by etoposide.
Abratt RP; Levin W
Cancer Treat Rep; 1985 Feb; 69(2):235. PubMed ID: 2982492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
